Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ·Healthcare·Biotechnology
$16.12
-1.53%
Mkt Cap $2.10B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $74.70M | $77.11M | +3.24% | $0.21 | $0.26 | +23.81% | — | — |
| Q4 2025 Nov 4, 2025 | $74.70M | $73.47M | -1.64% | $0.16 | $0.23 | +43.75% | — | — |
| Q3 2025 Jul 31, 2025 | $67.70M | $70.01M | +3.40% | $0.17 | $0.16 | -5.88% | — | — |
| Q2 2025 May 12, 2025 | $64.64M | $62.47M | -3.36% | $0.08 | $0.16 | +100.00% | — | — |
| Q1 2025 Feb 27, 2025 | $61.83M | $59.87M | -3.18% | $0.03 | $0.09 | +200.00% | — | — |
| Q4 2024 Nov 7, 2024 | $65.06M | $67.77M | +4.17% | $0.01 | $0.10 | +566.67% | — | — |
| Q3 2024 Aug 1, 2024 | $55.05M | $57.19M | +3.89% | $0.02 | $0.02 | +20.05% | — | — |
| Q2 2024 May 2, 2024 | $47.45M | $50.30M | +6.01% | -$0.17 | -$0.03 | +82.35% | — | — |
| Q2 2024 Apr 16, 2024 | — | $45.09M | — | -$0.14 | -$0.07 | +50.00% | — | — |
| Q4 2023 Nov 2, 2023 | $38.50M | $54.52M | +41.60% | -$0.17 | -$0.09 | +47.06% | — | — |
| Q3 2023 Aug 3, 2023 | $38.15M | $41.49M | +8.77% | -$0.18 | -$0.08 | +55.56% | — | — |
| Q2 2023 May 4, 2023 | $27.87M | $34.41M | +23.46% | -$0.22 | -$0.18 | +18.18% | — | — |
| Q1 2023 Feb 28, 2023 | $27.77M | $28.43M | +2.38% | -$0.27 | -$0.18 | +33.33% | — | — |
| Q4 2022 Nov 3, 2022 | $36.19M | $55.78M | +54.15% | -$0.17 | -$0.06 | +64.71% | — | — |
| Q3 2022 Aug 4, 2022 | $27.04M | $28.19M | +4.25% | -$0.22 | -$0.25 | -13.64% | — | — |
| Q2 2022 May 10, 2022 | $19.23M | $21.63M | +12.45% | -$0.27 | -$0.27 | +0.00% | — | — |
| Q1 2022 Feb 28, 2022 | $22.00M | $23.40M | +6.41% | -$0.27 | -$0.25 | +7.41% | — | — |
| Q4 2021 Nov 3, 2021 | $40.00K | $14.67M | +36567.50% | -$0.33 | -$0.39 | -18.18% | — | — |
| Q3 2021 Aug 5, 2021 | $40.00K | $6.62M | +16450.00% | -$0.36 | -$0.37 | -2.78% | — | — |
| Q2 2021 May 6, 2021 | $40.00K | $914.00K | +2185.00% | -$0.36 | -$0.40 | -11.11% | — | — |